News & Events about Staar Surgical Co.
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses, today announced a partnership with actress and beauty entrepreneur, Peyton List, to further its mission of bringing EVO Implantable Collamer Lenses (EVO) to the millions of Americans who...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported preliminary sales for the fourth quarter and fiscal year ended December 30, 2022. Preliminary net sales were approximately $64 million for the fourth quarter and...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that President and Chief Executive Officer Caren Mason will be retiring December 31, 2022, after leading the company through a significant period of...
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Swiss National Bank grew its holdings in STAAR Surgical (NASDAQ:STAA Get Rating) by 7.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The institutional investor owned 90,000 shares of the medical instruments ...